Pfizer says they are working on Omicron specific vaccine if needed.
Pfizer and BioNTech says its preliminary lab tests suggest a third dose of its vaccine is providing strong protection agains the Omicron variant.
With health officials urging people to get a third dose, Pfizer has released a study on whether booster shots of its COVID-19 vaccine may make an important difference.
The company says a booster dose may offer significant protection against the new Omicron variant even though the initial two doses appear significantly less effective.
Pfizer-BioNTech says its already working on creating an Omicron-specific vaccine and could have it ready for March of 2022 if needed.
Niagara Transit to Receive Gas Tax Money
Local Power Company Upgrading Technology
Police Called Concerning Armed Individual
Man Arrested in Connection to School Threats
110kms to be Permanent on Certain Highways
Suspect Sought After Cannabis Store Robbery
Mayor Looking at 'Silly Ways' to Control Speed
No Injuries After Shots Fired at House